{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:54:35Z","timestamp":1787504075597,"version":"build-2736575974"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Diabetes mellitus and dyslipidemia are major risk factors for atherosclerosis. Hypoechoic plaques, which indicate vulnerable or unstable plaques, may rupture and lead to ischemic stroke, cognitive impairment, increased adverse cardiac events, and even death. This study aimed to investigate the correlation between plasma lipid levels and the characteristics of atherosclerotic plaques in adult patients with type 2 diabetes mellitus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on adult patients with type 2 mellitus who were hospitalized in the Department of Endocrinology at Affiliated Hospital of Hebei University between January 2017 and December 2021.Patients were categorized into two groups based on arterial ultrasound results. Statistical analyses were performed to compare plasma lipid levels and plaque characteristics across the groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      1) Statistically significant differences were observed among the two groups in terms of gender, hypertension, age, duration of diabetes mellitus, plaque location, triglycerides (TG),total cholesterol (TC), Apolipoprotein A1 (Apo A1),very-low-density lipoprotein (VLDL), VLDL\/apolipoprotein B(ApoB), high-density lipoprotein cholesterol (HDL)\/ApoA1 (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;0.05). 2) Univariate and multivariate regression analyses revealed that VLDL,VLDL\/ApoB and HDL\/ApoA1 were correlated with plaque stability, the higher the levels of VLDL,VLDL\/ApoB and HDL\/ApoA1,the more likely they were to be hypoechoic plaque group (OR&amp;gt;1,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;0.05). 3) VLDL, VLDL\/ApoB and HDL\/ApoA1 showed predictive value for determining whether patients with type 2 diabetes had stable plaques. The area under the receiver operating characteristic (ROC) curve for VLDL, VLDL\/ApoB and HDL\/ApoA1 respectively were 0.789,0.779 and 0.728.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In clinical practice, the characteristics of atherosclerotic plaques and lipid profiles should be jointly evaluated to guide targeted treatment and effectively reduce the risk of atherosclerotic cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcdhc.2025.1688715","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:16:54Z","timestamp":1764566214000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlations between lipid profiles and atherosclerotic plaque characteristics in adult patients with type 2 diabetes mellitus"],"prefix":"10.3389","volume":"6","author":[{"given":"Lili","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiameng","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0036","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"46","author":"Sacks","year":"2023","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S001","article-title":"1. Improving care and promoting health in populations: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases:molecular mechanisms and therapeutic strategies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis:epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.840579","article-title":"Causal association of type 2 diabetes mellitus and glycemic traits with cardiovascular diseases and lipid traits: A Mendelian randomization study","volume":"13","author":"Huang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(06)68967-8","article-title":"Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study","volume":"368","author":"Booth","year":"2006","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht142","article-title":"Diabetes and vascular disease:pathophysiology, clinical consequences, and medical therapy: part II","volume":"34","author":"Beckman","year":"2013","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30010-9","article-title":"The changing face of diabetes complications","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12933-021-01344-0","article-title":"CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries","volume":"20","author":"Mosenzon","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034986","article-title":"Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus","volume":"138","author":"McAllister","year":"2018","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.12.3357","article-title":"High prevalence of peripheral arterial disease but low antiplatelet treatment rates in elderly primary care patients with diabetes","volume":"26","author":"Lange","year":"2003","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2011.02.001","article-title":"Prevalence and clinical profile and management of peripheral arterial disease in elderly patients with diabetes","volume":"22","author":"Escobar","year":"2011","journal-title":"Eur J Intern Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: A scientific statement from the American heart association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update:Cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus - mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics\u20142018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S010","article-title":"Cardiovascular disease and risk management: standards of care in diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-ad09a","article-title":"10. Cardiovascular disease and risk management: standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.arteri.2014.04.002","article-title":"Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception","volume":"26","author":"Plana","year":"2014","journal-title":"Clin Investig Arterioscler"},{"key":"B24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.10.009","article-title":"Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China","volume":"10","author":"Yan","year":"2016","journal-title":"J Clin Lipidol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3760\/cma.j.cn115791-20240301-00090","article-title":"Chinese expert consensus on lipid management for patients with diabetes (2024 edition)","volume":"16","year":"2024","journal-title":"Chin J Diabetes Mellitus"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1000-3614.2023.03.001","article-title":"Chinese lipid management guidelines (2023)","volume":"38","year":"2023","journal-title":"Chin Circ J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","article-title":"Clinical review on triglycerides","volume":"41","author":"Laufs","year":"2020","journal-title":"Eur Heart J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.04.082","article-title":"Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy","volume":"50","author":"Kubo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1168.e1","DOI":"10.1016\/j.recesp.2011.09.014","article-title":"Gu\u00eda de la ESC\/EAS sobre el manejo de las dislipemias [ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"64","author":"Reiner","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.006091","article-title":"Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis","volume":"46","author":"Gupta","year":"2015","journal-title":"Stroke"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13017","article-title":"Carotid plaque echogenicity predicts cerebrovascular symptoms:a systematic review and meta-analysis","volume":"23","author":"Jashari","year":"2016","journal-title":"Eur J Neurol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.17.2171","article-title":"Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis:the troms\u00f8 study","volume":"103","author":"Mathiesen","year":"2001","journal-title":"Circulation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1038\/s41598-017-02435-3","article-title":"Association between carotid plaque and cognitive impairment in Chinese stroke population : the SOS-stroke study","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00249-X","article-title":"Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II):a prospective natural history study","volume":"397","author":"Erlinge","year":"2021","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2023.08.006","article-title":"Coronary plaque characteristics associated with major adverse cardiovascular events in atherosclerotic patients and lesions:A systematic review and meta-analysis","volume":"16","author":"Gallone","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1606915","article-title":"Acute myocardial infarction","volume":"376","author":"Anderson","year":"2017","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00769-8","article-title":"Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research","volume":"20","author":"Gaba","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5551\/jat.49551","article-title":"Clinical Impact of Carotid Plaque Score rather than Carotid Intima-Media Thickness on Recurrence ofAtherosclerotic Cardiovascular Disease Events","volume":"27","author":"Tada","year":"2020","journal-title":"J Atheroscler Thromb"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-er09","article-title":"Erratum. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes-2016","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"B47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","article-title":"Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine","volume":"21","author":"Stein","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"B48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jacc.2009.02.068","article-title":"Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome","volume":"54","author":"Motoyama","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.310296","article-title":"Carotid artery remodeling is segment specific: an in vivo study by vessel wall magnetic resonance imaging","volume":"38","author":"Watase","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32233-9","article-title":"Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70\u2013100 years: a contemporary primary prevention cohort","volume":"396","author":"Mortensen","year":"2020","journal-title":"Lancet"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2019.07.008","article-title":"Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control","volume":"288","author":"Vallejo-Vaz","year":"2019","journal-title":"Atherosclerosis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-020-0989-8","article-title":"The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China","volume":"19","author":"Qin","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0501","article-title":"Residual hypertriglyceridemia and estimated atherosclerotic cardiovascular disease risk by statin use in U.S. Adults with diabetes: national health and nutrition examination survey 2007-2014","volume":"42","author":"Fan","year":"2019","journal-title":"Diabetes Care"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12020438","article-title":"Electronegative LDL is associated with plaque vulnerability in patients with ischemic stroke and carotid atherosclerosis","volume":"12","author":"Puig","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705013361802","article-title":"Coronary risk factors and plaque morphology in men with coronary disease who died suddenly","volume":"336","author":"Burke","year":"1997","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"J\u00f8rgensen","year":"2013","journal-title":"Eur Heart J"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.03.544","article-title":"Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins","volume":"65","author":"Schwartz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab705","article-title":"Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke:a cohort-based study","volume":"43","author":"Wadstr\u00f6m","year":"2022","journal-title":"Eur Heart J"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab293","article-title":"Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction","volume":"42","author":"Varbo","year":"2021","journal-title":"Eur Heart J"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.032318","article-title":"Triglyceride-rich lipoprotein cholesterol and risk of cardiovascular events among patients receiving statin therapy in the TNT trial","volume":"138","author":"Vallejo-Vaz","year":"2018","journal-title":"Circulation"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25432","article-title":"Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population","volume":"85","author":"Varbo","year":"2019","journal-title":"Ann Neurol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1177\/2047487319887578","article-title":"Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease","volume":"27","author":"Elshazly","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2025.07.001","article-title":"Histologically verified carotid plaque characteristics by ultrasound: A diagnostic accuracy systematic review","volume":"51","author":"Pakizer","year":"2025","journal-title":"Ultrasound Med Biol"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2025.1688715\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:16:57Z","timestamp":1764566217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2025.1688715\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":69,"alternative-id":["10.3389\/fcdhc.2025.1688715"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2025.1688715","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"1688715"}}